. 2019 Oct 1;23(12):8292–8304. doi: 10.1111/jcmm.14705

Table 1.

Correlation between the clinicopathologic characteristics and miR‐1914 and GPR39 expression in HCC (n = 134)

Clinical parameters	Cases	Expression level		P value	Expression level		P value
Clinical parameters	Cases	miR‐1914^high (n = 65)	miR‐1914^low (n = 69)	P value	GPR39^high (n = 70)	GPR39^low (n = 64)	P value
Age (y)
<65 y	71	33	38	.618	35	36	.469
≥65 y	63	32	31		35	28
Gender
Male	108	52	56	.865	56	52	.855
Female	26	13	13		14	12
Tumour size (cm)
＜5 cm	105	57	48	.011*	48	57	.004*
≥5 cm	29	8	21		22	7
Tumour number
Solitary	116	57	59	.711	60	56	.762
Multiple	18	8	10		10	8
Edmondson
Ⅰ+Ⅱ	97	55	42	.002*	45	52	.028*
Ⅲ+Ⅳ	37	10	27		25	12
TNM stage
Ⅰ+Ⅱ	109	58	51	.023*	56	53	.676
Ⅲ+Ⅳ	25	7	18		14	11
Capsular
Present	93	46	47	.739	46	47	.333
Absent	41	19	22		24	17
Venous invasion
Present	17	8	9	.898	10	7	.561
Absent	117	57	60		60	57
AFP
＜400 ng/mL	36	16	20	.568	19	17	.940
≥400 ng/mL	98	49	49		51	47
HBsAg
Positive	120	59	61	.655	63	57	.859
Negative	14	6	8		7	7

Abbreviations: AFP, alpha‐fetoprotein; HCC, hepatocellular carcinoma; TNM, tumour‐node‐metastasis.

P < .05.